Your Messages Inbox
Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
See Latest ArticlesManagement of osteoporosis in the aging male: Focus on zoledronic acid
Clinical Interventions in Aging, 06/18/09
Piper Jr PK et al. - Osteoporosis in the aging male remains an important yet under-recognized and undertreated disease. Current US estimates indicate that over 14 million men have osteoporosis or low bone mass, and men suffer approximately 500,000 osteoporotic fractures each year. Men experience fewer osteoporotic fractures than women but have higher mortality after fracture. Bisphosphonates are potent antiresorptive agents that inhibit osteoclast activity, suppress in vivo markers of bone turnover, increase bone mineral density, decrease fractures, and improve survival in men with osteoporosis. Intravenous zoledronic acid may be a preferable alternative to oral bisphosphonate therapy in patients with cognitive dysfunction, the inability to sit upright, or significant gastrointestinal pathology. Zoledronic acid (Reclast) is approved in the US as an annual 5 mg intravenous infusion to treat osteoporosis in men. The zoledronic acid (Zometa) 4 mg intravenous dose has been studied in the prevention of bone loss associated with androgen deprivation therapy.
Related Articles
Osteologix to Continue Development of Osteoporosis Drug
Internet Source, 10/21/09
Relevance Score: 93%
Lifestyle increases osteoporosis risk: docs
Internet Source, 10/21/09
Relevance Score: 90%
Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
Clinical Interventions in Aging, 11/12/09
Relevance Score: 89%
A microarray based identification of osteoporosis-related genes in primary culture of human osteoblasts
Bone, 10/27/09
Relevance Score: 89%
Evaluation of Compliance with Osteoporosis Treatment Guidelines After Initiation of a Pharmacist-Run Osteoporosis Service at a Family Medicine Clinic
Annals of Pharmacotherapy, 10/15/09
Relevance Score: 89%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of the patient with medically refractory epilepsy
Expert Review of Neurotherapeutics, 12/09/09
Effect of Atorvastatin on Platelet Thromboxane A2 Synthesis in Aspirin-Treated Patients With Acute Myocardial Infarction
The American Journal of Cardiology, 12/09/09
A Randomized Controlled Trial of Oxycodone vs Placebo in Patients With PostHerpetic Neuralgia and Painful Diabetic Neuropathy Treated With Pregabalin
The Journal of Pain, 12/09/09
Today in Geriatrics...keeping you current
Receive free subspecialty "5-minute updates" via email
Undernutrition and housebound older people
Nutrition & Dietetics, 12/09/09
Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD)
Archives of Gerontology and Geriatrics, 12/09/09
Postendarterectomy Mortality in Octogenarians and Nonagenarians in the USA from 1993 to 1999
Cerebrovascular Diseases, 12/09/09
Today in Men`s Health...keeping you current
Receive free subspecialty "5-minute updates" via email
Sexual Dysfunction in an Internet Sample of U.S. Men Who Have Sex with Men
The Journal of Sexual Medicine, 12/09/09
Correlations between lower urinary tract symptoms, erectile dysfunction, and cardiovascular diseases: Are there differences between male populations from primary healthcare and urology clinics? A review of the current knowledge
The European Journal of General Practice, 12/08/09
LH, Non-SHBG Testosterone and Estradiol Levels during Testosterone Replacement of Hypogonadal Men: Further Evidence that Steroid Negative Feedback Increases as Men Grow Older
Journal of Andrology, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor